Novo-midlerne Wegovy og Ozempic er blandt 15 lægemidler, som den amerikanske regering har udvalgt til prisforhandlinger under ...

Lægemiddelstyrelsen i USA, FDA, har tirsdag godkendt Novo Nordisks diabetesmiddel Ozempic til behandling af kronisk ...

Ozempic er udviklet af den danske medicinalgigant Novo Nordisk. Det er et diabetesmiddel ... Drømmer du om sene efterårshindbær i din have, så skal du endelig ikke tøve med at kontakte Michelle fra ...

Kiloene rasler af befolkningen verden over, efter at Novo Nordisk sendte først Ozempic og senere Wegovy på markedet ... under menupunktet ‘Tilladelser & Services’ på din ING/Profil. Du skal acceptere ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has been approved to reduce the risk of kidney disease worsening, kidney failure, and death from ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

(Image Credits: Pixabay) The United States Food and Drug Administration (USFDA) has approved Novo Nordisk’s Ozempic for reducing the risk of kidney failure and disease progression. According to ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

When Novo Nordisk unveiled kidney outcomes data for its star GLP-1 medicine Ozempic last May, the company’s executive medical director suggested the results could help set a new standard for ...